Showing results (111-120 of 124) with videos related to
Sort By:
Pageof 13
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2024
Exploring Definitions and Predictors of Response to Biologics for Severe AsthmaGhislaine Scelo, Trung N Tran, Tham T Le, et al.Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.Scientific Data|May 16, 2015
A comprehensive collection of systems biology data characterizing the host response to viral infectionBrian D Aevermann, Brett E Pickett, Sanjeev Kumar, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.Pageof 13